AG
IBRX icon

Artal Group’s ImmunityBio IBRX Stock Holding History

Artal Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-225,000
Closed -$1.01M – 138
2017
Q4 		$1.01M Hold
225,000
– – 0.02% 113
2017
Q3 		$1.23M Hold
225,000
– – 0.02% 103
2017
Q2 		$1.71M Hold
225,000
– – 0.04% 97
2017
Q1 		$799K Hold
225,000
– – 0.02% 91
2016
Q4 		$1.29M Hold
225,000
– – 0.03% 83
2016
Q3 		$1.75M Hold
225,000
– – 0.04% 87
2016
Q2 		$1.4M Hold
225,000
– – 0.03% 66
2016
Q1 		$1.85M Hold
225,000
– – 0.04% 55
2015
Q4 		$3.9M Buy
225,000
+50,000
+29% +$742K 0.09% 67
2015
Q3 		$2.01M Buy
+175,000
New +$3.82M 0.06% 68

Other funds holding IBRX

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return